Litcius/Paper detail

Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives

Jiarui Hu, Dan Zhang, Keyue Tian, Changyu Ren, Heng Li, Congcong Lin, Xiaoli Huang, Jie Liu, Wuyu Mao, Jifa Zhang, Jifa Zhang

2023European Journal of Medicinal Chemistry56 citationsDOIOpen Access PDF

Topics & Concepts

LRRK2ChemistrySmall moleculeNeuroinflammationAutophagyLeucine-rich repeatCell biologyParkinson's diseaseKinasePharmacologyNeuroscienceBiochemistryBiologyDiseaseMedicinePathologyApoptosisParkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsBiotin and Related Studies
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives | Litcius